Groupe Bruxelles Lambert (GBLB) Q3 2024 & Strategy Update earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 & Strategy Update earnings summary
16 Jan, 2026Executive summary
Strategic focus on increasing private asset allocation to 50% of the portfolio by 2027, with a balanced approach between listed and private investments and a proven value creation playbook.
Emphasis on disciplined capital allocation, maintaining conservative leverage, and opportunistic investments as market conditions improve.
Commitment to growing NAV per share, increasing annual dividends, and continuing share buybacks while trading at a significant discount to NAV.
Strong family and permanent capital DNA differentiates the investment approach, enabling agility and long-term partnerships.
Portfolio rotation has increased the weight of private investments from 17% in 2021 to 36% as of September 2024.
Financial highlights
Portfolio valued at €17 billion, with NAV at €16.3bn as of September 2024 and NAV per share up 3.8% to €117.99.
€2 billion spent on share buybacks over recent years, with 2.8m shares repurchased for €190m in 9M 2024.
Recent divestment of €1.7 billion in Adidas shares, generating a 2.9x MOIC and €1.1 billion capital gain.
Dividend per share proposed at €5.00 for FY 2024, up 82% year-over-year, with a yield of 7.1%.
Market capitalization at €9.7bn, with a 40.7% discount to NAV.
Outlook and guidance
Targeting double-digit total shareholder return (TSR) per annum through 2027, driven by NAV/share growth and increasing distributions.
Portfolio allocation by 2027: ~50% listed, ~30-35% direct private, ~15-20% indirect private, and profitable asset management.
Commitment to steady dividend growth from the new €5.00 base and continued opportunistic share buybacks.
Plans to redeploy and return ~€7bn over FY 2024-2027, split between new investments and shareholder returns.
Latest events from Groupe Bruxelles Lambert
- Zero net debt, leadership change, 80% dividend hike, and strategic pivot to private assets.GBLB
AGM 202529 Nov 2025 - Portfolio simplification, strong healthcare growth, and enhanced shareholder returns marked the period.GBLB
Q3 20257 Nov 2025 - Record dividend, €0.8bn disposals, and private asset growth drove robust shareholder returns.GBLB
Q2 20258 Sep 2025 - GBL achieved meaningful growth in H1 2024, raising its dividend and strengthening its portfolio.GBLB
Investor Presentation13 Jun 2025 - NAV per share remained strong as asset rotation and dividend growth drove performance.GBLB
Q2 202413 Jun 2025 - NAV per share at €111.17, dividend up 82%, and private assets drive portfolio growth.GBLB
Q1 20255 Jun 2025 - 82% dividend hike and private asset growth drive mid-term value creation and TSR.GBLB
Q4 20245 Jun 2025